Trial intelligence / Profile preview

Paediatric Sternotomy Scar Management

ACTRN12617000813381Phase 4Terminated

Sponsor
The Children's Hospital at Westmead
Start
Sep 2019
Modality
Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of kelocote and sorbolene with vitamin E in hypertrophic scar and surgical scar (2 arms), sponsored by The Children's Hospital at Westmead. Started Sep 2019; status: terminated.

02

Drugs

kelocotesorbolene with vitamin E
03

Conditions

hypertrophic scarsurgical scar

Beyond the preview

Go deeper on ACTRN12617000813381.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12617000813381.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call